Controlled Substances - As enacted, clarifies that a substance that is approved by the U.S. food and drug administration and designated or scheduled under federal law by a final order published in the Federal Register is generally considered to be in the same schedule as such substance is designated or scheduled under the federal schedule of controlled substances after the expiration of 30 days from the date of publication of the final order; authorizes a licensed healthcare prescriber who is...

Summary

The bill requires the state Department of Health to compile a list of every medication the FDA has approved for women's health, include a brief description of each, and send that report to the Senate and House speakers before the start of 2027. It amends several sections of the Tennessee Code but does not create new programs or funding. The measure aims to give lawmakers a clear view of available women’s‑health medicines.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share